Johnson & Johnson Halts Study Due To Liver Safety Concerns

09:31 EDT 18 May 2018 | PharmPro

News
Serious liver enzymes have been in observed in some participants, prompting the company to stop the Alzheimer's disease study.
Staff Author: 
Topics: 

Original Article: Johnson & Johnson Halts Study Due To Liver Safety Concerns

More From BioPortfolio on "Johnson & Johnson Halts Study Due To Liver Safety Concerns"